当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析

丸美生物

(603983)

  

流通市值:134.50亿  总市值:134.50亿
流通股本:4.01亿   总股本:4.01亿

丸美生物(603983)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.47亿元,每股收益0.61元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益339128.60万元,未分配利润196235.05万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产484662.29万元,负债145533.69万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,450,380,539.411,764,646,729.2846,648,701.632,969,770,566.54
营业总成本2,206,220,208.731,550,885,924.71684,279,945.762,610,212,848.29
其他经营收益
营业利润299,077,057.09229,120,922.85165,983,550.75380,936,810.22
利润总额298,521,477.37228,852,497.48166,151,487.8380,656,508.96
净利润246,649,316.64174,712,447.04135,197,697.18342,363,890.32
每股收益
其他综合收益-73,087.1-112,116.33-59,597.35-124,364.71
综合收益总额246,576,229.54174,600,330.71135,138,099.83342,239,525.61
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,594,081,776.342,559,616,186.952,641,018,361.332,954,402,626.08
非流动资产:
非流动资产合计2,252,541,082.772,198,728,829.812,138,770,852.452,108,161,468.73
资产总计4,846,622,859.114,758,345,016.764,779,789,213.785,062,564,094.81
流动负债:
流动负债合计1,436,832,268.971,322,663,067.441,180,868,219.111,596,540,138.86
非流动负债:
非流动负债合计18,504,584.4616,121,842.4818,135,803.8319,520,458.19
负债合计1,455,336,853.431,338,784,909.921,199,004,022.941,616,060,597.05
所有者权益(或股东权益):
归属于母公司股东权益合计3,323,476,059.973,354,205,421.093,515,392,384.833,380,406,892.85
股东权益合计3,391,286,005.683,419,560,106.843,580,785,190.843,446,503,497.76
负债和股东权益合计4,846,622,859.114,758,345,016.764,779,789,213.785,062,564,094.81
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,558,200,460.241,839,573,690.11954,056,827.42,777,639,441.46
经营活动现金流出小计2,399,327,220.711,660,043,855.72981,644,388.672,477,112,583.11
经营活动产生的现金流量净额158,873,239.53179,529,834.39-27,587,561.27300,526,858.35
投资活动产生的现金流量:
投资活动现金流入小计157,352,229.43157,330,350.3796,330,024.031,400,120,250.13
投资活动现金流出小计324,299,465.9235,365,414.78124,236,457.12967,928,649.87
投资活动产生的现金流量净额-166,947,236.47-78,035,064.41-27,906,433.09432,191,600.27
筹资活动产生的现金流量:
筹资活动现金流入小计440,309,091.9415,388,536.34-786,676,783.33
筹资活动现金流出小计823,106,804.3772,550,724.5151,633,336.23979,825,800.28
筹资活动产生的现金流量净额-382,797,712.4-357,162,188.16-151,633,336.23-193,149,016.95
汇率变动对现金及现金等价物的影响25,235.78124,244.9820,332.55-48,386.26
现金及现金等价物净增加额-390,846,473.56-255,543,173.2-207,106,998.04539,521,055.4
期末现金及现金等价物余额1,188,213,536.381,323,516,836.741,371,953,011.91,579,060,009.94
补充资料:
现金及现金等价物的净增加额--255,543,173.2-539,521,055.4
最新报告期:2025-11-12
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
野村东方国际证券张影秋,曾万霖0.911.131.372025-11-12
兴业证券代凯燕0.921.171.392025-11-12
长城证券黄淑妍0.941.171.432025-11-10
长江证券李锦,罗祎0.951.121.292025-11-09
中信证券张琳,徐晓芳,杜一帆0.981.181.432025-11-06
TOP↑